内华达州亨德森 - 目前股价为每股0.64美元的跨国表观遗传学公司VolitionRx Limited (NYSE AMERICAN: VNRX)在其2024年业务回顾中报告了过去一年的主要成就。根据 InvestingPro 的数据，该公司在过去十二个月内实现了97.5%的可观收入增长，尽管分析师指出预计今年该公司不会盈利。公司已将其Nu.Q® ...

Geode Capital Management LLC boosted its stake in shares of VolitionRx Limited (NYSE:VNRX – Free Report) by 15.1% in the 3rd quarter, HoldingsChannel reports. The fund owned 730,448 shares of the ...

VolitionRx Limited (NYSEAMERICAN:VNRX – Get Free Report)’s stock price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0 ...

Based on the one-year price targets offered by 4 analysts, the average target price for VolitionRX Ltd (VNRX) is $3.28 with a high estimate of $5 and a low estimate of $2. The average target ...

Highlights,VolitionRx focuses on epigenetics to aid in early cancer and disease detection.,Company’s market cap stands at $56 ...

VolitionRx Limited (AMEX:VNRX) Q3 2024 Earnings Call Transcript November 15, 2024 Operator: Good day, ladies and gentlemen. Thank you for standing by. Welcome to VolitionRx Limited's Third Quarter ...

6, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition" or the "Company"), a multi-national epigenetics company, announced today that it has entered into definitive agreements ...

VolitionRX（VNRX.US）公司简介：VolitionRX Ltd是一家总部位于美国的表观遗传学公司，通过其子公司应用 Nucleosomics 平台开发简单、易于使用、具有成本 ...

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition" or the "Company"), a multi-national epigenetics company, announced that it has retained LifeSci Advisors, LLC ("LSA") a premiere life sciences ...

6, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition" or the "Company"), a multi-national epigenetics company, announced today that it has entered into definitive agreements for ...

HENDERSON, Nev. , Nov. 14, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces financial results and a business update for ...